Serious Clinical Trial Violations Down In FY 2005 – FDA’s Marcarelli
This article was originally published in The Gray Sheet
Executive Summary
Device companies showed marked improvement in complying with FDA clinical trial regulations during the past year, according to FDA
You may also be interested in...
“For Cause” Inspections Find Galloping Clinical Trial Violation Rate
The violation rate for clinical trial sponsors shot up in fiscal year 2007, hitting a 10-year high, with FDA finding many of the problems during inspections triggered by complaints, according to CDRH
“For Cause” Inspections Find Galloping Clinical Trial Violation Rate
The violation rate for clinical trial sponsors shot up in fiscal year 2007, hitting a 10-year high, with FDA finding many of the problems during inspections triggered by complaints, according to CDRH
Plus Orthopedics No Longer Facing FDA “Application Integrity” Restrictions
Smith & Nephew's new subsidiary Plus Orthopedics was removed from FDA's Application Integrity Policy (AIP) list Sept. 14 after three years of working with the agency to resolve its clinical trial issues